Inventor

GIL DANIEL W

US79 patents

⚠️ This page may combine multiple inventors who share the name “GIL DANIEL W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GIL DANIEL W

ALLERGAN INC

Methods and compositions for alleviating pain

Nonsedating α-2 agonists

Imidiazoles having reduced side effects

Agent and methods for treating pain

(2-hydroxy)ethyl-thioureas useful as modulators of α2B adrenergic receptors

Methods and compositions for modulating alpha adrenergic receptor activity

Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] methanol for treating retinal diseases

4-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists

Methods of preventing and reducing the severity of stress-associated conditions

Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions

2-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronapthalen-1(2H)-one

4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds

Nonsedating α-2 agonists

Pharmaceutical compositions comprising (3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl)methanol

Treatment of inflammatory bowel disease

Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases

Heavy chain only antibodies to ANG-2

Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists

Methods for detecting receptor modulator activity

Alpha-2-adrenergic receptor agonists for treatment of presbyopia, visual glare, visual starbursts, visual halos and night myopia

Methods of treating α adrenergic mediated conditions

Methods of treating α adrenergic mediated conditions

4-(Phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists

4-(Condensed cyclicmethyl)-imidazole-2-thiones acting as α2 adrenergic agonists

Method for identifying muscarinic agents lacking miotic side effects

Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases

Heavy chain only antibodies to ANG-2

Heavy chain only antibodies to PDGF

Heavy chain only antibodies to PDGF

Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists

Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists

Treatment of inflammatory bowel disease

Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases

Treatment of inflammatory bowel disease

Nucleic acid encoding a novel human EP prostaglandin receptor

ALLERGAN SALES INC

Methods of treating pain and other conditions

Method for treating ocular pain

Methods and compositions for modulating alpha adrenergic receptor activity

Methods and compositions for modulating alpha adrenergic receptor activity

CHOW KEN

Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol

Alpha adrenergic receptor modulators

Aryl fluoroethyl ureas acting as alpha 2 adrenergic agents

DIBAS MOHAMMAD I

Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating retinal diseases

Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating skin diseases and conditions

GIL DANIEL W

Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists

NGUYEN PHONG X

Selective alpha 2B/2C agonists

LUHRS LAUREN M B

Method of treating sensorimotor disorders with alpha-2 adrenergic receptor agonists

FANG WENKUI K

Methods of treating alpha adrenergic mediated conditions

UNIV ARIZONA

Antibodies directed towards a novel human EP prostaglandin receptor

DONDE YARIV

Geminal dialkyl prostanoids